ArticleCancer chemotherapy and pharmacology2017

A phase I study of afatinib combined with paclitaxel and bevacizumab in patients with advanced solid tumors.

James Spicer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.